Pain mechanisms in psoriatic arthritis

At the European Alliance of Associations for Rheumatology (EULAR) Congress 2024, our Steering Committee member Peter Nash, Griffith University, Queensland, AU, interviewed Kurt De Vlam, KU Leuven, Leuven, BE about his current work in psoriatic arthritis (PsA). 

De Vlam explains his research on metabolic profiling in PsA, particularly the role of lipids in disease initiation. He then focuses on his studies exploring different types of pain mechanisms in PsA, highlighting how a greater understanding of this might influence treatment selection. Finally, De Vlam  discusses the role of Janus kinase (JAK) inhibitors in the treatment of PsA, especially in patients with higher pain levels.